insights_auto
Why is TNDM up 2,78%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
16,11 $
arrow_upward
+2,78%(+0,44) 1D
16,11 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
15,64 $
High
16,13 $
Low
15,38 $
Mkt. cap
1,12 մլրդ
Avg. vol.
2,04 մլն
Volume
1,43 մլն
52-wk high
29,65 $
52-wk low
12,26 $
EPS
-0,93 $
Beta
1,66
Shares outstanding
69,58 մլն
No. of employees
2 հզր
Open
15,64 $
High
16,13 $
Low
15,38 $
Mkt. cap
1,12 մլրդ
Avg. vol.
2,04 մլն
Volume
1,43 մլն
52-wk high
29,65 $
52-wk low
12,26 $
EPS
-0,93 $
Beta
1,66
Shares outstanding
69,58 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
15 ժամ առաջ
Tandem Diabetes Care (TNDM) Could Be 45% Undervalued After Tandem Mobi Europe Launch
Zacks
·
1 օր առաջ
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
Yahoo Finance
·
1 օր առաջ
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
AD HOC NEWS
·
2 օր առաջ
Barclays keeps Tandem Diabetes Care stock at Hold with USD 18.00 target
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc